secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001824293-24-000052
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio enters into ATM equity offering agreement with H.C. Wainwright for up to $961,579
--------------------------------------------------------------------------------

- Company may sell up to $961,579 of common stock through H.C. Wainwright as sales agent.
- Wainwright receives 3% commission on gross proceeds; no obligation for Company to sell.
- Shares offered on Nasdaq as at-the-market sales under May 20, 2024 prospectus supplement.
- Company can suspend or terminate the agreement at any time; $10M aggregate cap also applies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/0001824293-24-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000052/val-20240520.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer